Long-term Culture Change After Major Device Enforcement Actions This article serves as a comprehensive guide for regulatory, quality, clinical, and RA/QA professionals in the medical device industry who are navigating the complexities of culture change following major enforcement actions by the FDA. In the dynamic landscape of medical device regulation, understanding the implications of FDA inspections, QSIT, warning letters, and CAPA is crucial for sustained compliance and organizational improvement. Understanding FDA Inspections: QSIT Overview The FDA’s Quality System Inspection Technique (QSIT) is an essential framework for evaluating the quality systems of medical device manufacturers. Understanding QSIT leads to improved compliance,…

Training SMEs and Executives for High Stakes Device Inspection Meetings Training SMEs and Executives for High Stakes Device Inspection Meetings Understanding the Landscape of FDA Inspections The FDA is tasked with ensuring that medical devices meet rigorous standards for safety and effectiveness before they are made available to the public. This responsibility includes conducting inspections of manufacturing facilities, assessing compliance with the Quality System Regulation (QSR) under 21 CFR Part 820. For regulatory affairs (RA), quality assurance (QA), and clinical professionals, the implications of these inspections can be profound, particularly when it comes to preparing for high-stakes meetings with FDA…

Digital Tools and Trackers to Manage Inspection Actions and Deadlines In the highly regulated landscape of medical devices, maintaining compliance with FDA inspections, QSIT protocols, warning letters, and CAPA (Corrective and Preventive Action) processes is paramount for manufacturers. This article aims to provide regulatory and quality assurance professionals with a comprehensive guide to leveraging digital tools and trackers to effectively manage inspection actions and deadlines, ensuring inspection readiness and adherence to compliance requirements. Understanding FDA Inspections and QSIT Framework The U.S. Food and Drug Administration (FDA) is responsible for ensuring that medical devices are safe and effective. FDA inspections are…

Governance structures for tracking and closing device CAPA commitments Governance Structures for Tracking and Closing Device CAPA Commitments For professionals involved in the medical device industry, navigating the complex regulatory landscape of the U.S. Food and Drug Administration (FDA) is essential to ensuring compliance and maintaining operational excellence. This article provides a comprehensive, step-by-step tutorial on establishing effective governance structures for tracking and closing Corrective and Preventive Actions (CAPA) commitments. This is crucial for addressing findings from FDA inspections, QSIT assessments, and other regulatory engagements. Understanding FDA Inspections, QSIT, and CAPA The FDA plays a pivotal role in safeguarding public…

Linking Internal Audit Programs to QSIT and Warning Letter Trends The complexities of regulatory compliance within the medical device sector necessitate a structured approach to quality management. The FDA’s Quality System Inspection Technique (QSIT) and its insights into warning letters provide a framework that can significantly enhance internal audit programs. This comprehensive guide will walk you through the linkages between internal audit programs, QSIT, and warning letter trends, specifically tailored for professionals working with medical devices and combination products. Our focus will be on the regulatory expectations in the United States, with relevant comparisons to practices in the UK and…